Poorer survival of nulliparous women with endometrial carcinoma

Several epidemiologic studies have shown an inverse relationship between parity and the incidence of endometrial carcinoma. A prognostic influence of reproductive factors has been reported for carcinomas of the breast and uterine cervix; but no such independent influence has been reported for endometrial carcinoma, to the authors' knowledge. Therefore, the authors investigated the prognostic importance of parity in an unselected group of patients.

[1]  Bpg Secretariat.  Independent prognostic importance of microvessel density in endometrial carcinoma , 1998, British Journal of Cancer.

[2]  L. Akslen,et al.  Independent prognostic importance of microvessel density in endometrial carcinoma. , 1998, British Journal of Cancer.

[3]  L. Akslen,et al.  Recurrence of endometrial carcinoma and the value of routine follow up , 1997, British journal of obstetrics and gynaecology.

[4]  N. Weiss,et al.  Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women , 1997, The Lancet.

[5]  T. Bjørge,et al.  Reproductive factors and prognosis of uterine cervical cancer in Norway. , 1996, British Journal of Cancer.

[6]  B. Iacopetta,et al.  Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. , 1996, British Journal of Cancer.

[7]  Ó. Kravdal,et al.  The importance of childbearing for Hodgkin's disease: new evidence from incidence and mortality models. , 1996, International journal of epidemiology.

[8]  C. D. de Ridder,et al.  Endometrial cancer in a cohort screened for breast cancer , 1996, European Journal of Cancer Prevention.

[9]  R. Buller,et al.  Obesity and prognosis in endometrial cancer. , 1996, American journal of obstetrics and gynecology.

[10]  P. Sevelda,et al.  Influence of delayed diagnosis on established prognostic factors in endometrial cancer. , 1996, Anticancer research.

[11]  S. Vollset,et al.  Do reproductive factors influence colorectal cancer survival? , 1995, Journal of clinical epidemiology.

[12]  B. Modan,et al.  The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma. , 1995, American journal of obstetrics and gynecology.

[13]  Ivar Heuch,et al.  Is the risk of cancer of the corpus uteri reduced by a recent pregnancy? A prospective study of 765,756 norwegian women , 1995, International journal of cancer.

[14]  B. Karlan,et al.  HER‐2/neu, p53, and DNA Analyses as Prognosticators for Survival in Endometrial Carcinoma , 1995, Obstetrics and gynecology.

[15]  H. Stalsberg,et al.  Use of pap‐smears in a population without a mass screening program , 1994, Acta obstetricia et gynecologica Scandinavica.

[16]  P. Tartter,et al.  Reproductive history and prognosis in patients with operable breast cancer , 1994, Cancer.

[17]  S. Vollset,et al.  Reproductive factors and survival from ovarian cancer , 1993, International journal of cancer.

[18]  J. Mikuta.  International federation of gynecology and obstetrics staging of endometrial cancer 1988 , 1993, Cancer.

[19]  G. Wagenius,et al.  Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II. , 1992, Anticancer research.

[20]  L. Meyer,et al.  Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer , 1991, International journal of cancer.

[21]  V. Abeler,et al.  Endometrial adenocarcinoma in Norway. A study of a total population , 1991, Cancer.

[22]  C. la Vecchia,et al.  Reproductive factors and risk of endometrial cancer. , 1991, American journal of obstetrics and gynecology.

[23]  S. Tretli,et al.  Height and weight in relation to uterine corpus cancer in norway morbidity and mortality. A follow‐up study of 570,000 women in Norway , 1990 .

[24]  C. Marth,et al.  Prognostisch relevante Faktoren beim malignen Müllerschen Mischtumor , 1990 .

[25]  J D Habbema,et al.  Cervical‐cancer screening: Attendance and cost‐effectiveness , 1990, International journal of cancer.

[26]  S. Franceschi,et al.  Reproductive factors and cancers of the breast, ovary and endometrium. , 1989, European journal of cancer & clinical oncology.

[27]  Ivar Heuch,et al.  Reproductive factors and risk of cancer of the uterine corpus: a prospective study. , 1988, Cancer research.

[28]  W. P. Dixon,et al.  BMPD statistical software manual , 1988 .

[29]  J. Samet,et al.  Delay in seeking care for cancer symptoms: a population-based study of elderly New Mexicans. , 1988, Journal of the National Cancer Institute.

[30]  M. Pike,et al.  The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. , 1988, British Journal of Cancer.

[31]  O. Iversen.  Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma. , 1986, American journal of obstetrics and gynecology.

[32]  B. Greenberg,et al.  Predominance of early endometrial cancers after long-term estrogen use. , 1980, JAMA.

[33]  G. Malkasian,et al.  Endometrial Cancer Associated With Feminizing Ovarian Tumor and Polycystic Ovarian Disease , 1977, Obstetrics and gynecology.

[34]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[35]  J. Noumoff,et al.  Endometrial adenocarcinoma , 1993, Microscopy research and technique.

[36]  M. Black,et al.  Parity as a prognostic factor in young breast cancer patients. , 1983, Journal of the National Cancer Institute.

[37]  S. D. Mearses.  ENDOMETRIAL CARCINOMA. , 1963, The Medical journal of Malaya.

[38]  D.,et al.  Regression Models and Life-Tables , 2022 .